In the per-protocol population, stroke or systemic embolism occurred in 188 patients who received rivaroxaban and 241 patients who received warfarin (1.7 vs 2.2%; hazard ratio [HR]: 0.79; ...
Adapted with permission from [9,21]. Events Rivaroxaban (number per 100 patient years) Warfarin (number per 100 patient years) Rivaroxaban versus warfarin hazard ratio (95% CI) Primary safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback